158 related articles for article (PubMed ID: 24906211)
1. Hypokalemia and hypomagnesaemia related to levetiracetam use.
Aksoy D; Cevik B; Kurt S; Pekdas E; Solmaz V
J Clin Neurosci; 2014 Nov; 21(11):1989-90. PubMed ID: 24906211
[TBL] [Abstract][Full Text] [Related]
2. Levetiracetam-induced interstitial nephritis in a patient with glioma.
Mahta A; Kim RY; Kesari S
J Clin Neurosci; 2012 Jan; 19(1):177-8. PubMed ID: 22071460
[TBL] [Abstract][Full Text] [Related]
3. Levetiracetam-associated Hypokalemia and Hypomagnesaemia among Two Patients Treated for Seizures.
Vallianou NG; Geladari E; Chroni P; Kokkinakis E
CNS Neurosci Ther; 2015 Jun; 21(6):539. PubMed ID: 25899700
[No Abstract] [Full Text] [Related]
4. Levetiracetam and lamotrigine effects as mono- and polytherapy on bone mineral density in epileptic patients.
El-Haggar SM; Mostafa TM; Allah HMS; Akef GH
Arq Neuropsiquiatr; 2018 Jul; 76(7):452-458. PubMed ID: 30066796
[TBL] [Abstract][Full Text] [Related]
5. Haematological toxicity of Valproic acid compared to Levetiracetam in patients with glioblastoma multiforme undergoing concomitant radio-chemotherapy: a retrospective cohort study.
Tinchon A; Oberndorfer S; Marosi C; Gleiss A; Geroldinger A; Sax C; Sherif C; Moser W; Grisold W
J Neurol; 2015 Jan; 262(1):179-86. PubMed ID: 25359262
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures.
Lerche H; Daniluk J; Lotay N; DeRossett S; Edwards S; Brandt C
Seizure; 2015 Aug; 30():93-100. PubMed ID: 26216692
[TBL] [Abstract][Full Text] [Related]
7. Levetiracetam induces a rapid and sustained reduction of generalized spike-wave and clinical absence.
Cavitt J; Privitera M
Arch Neurol; 2004 Oct; 61(10):1604-7. PubMed ID: 15477517
[TBL] [Abstract][Full Text] [Related]
8. Levetiracetam: safety and efficacy in neonatal seizures.
Ramantani G; Ikonomidou C; Walter B; Rating D; Dinger J
Eur J Paediatr Neurol; 2011 Jan; 15(1):1-7. PubMed ID: 21094062
[TBL] [Abstract][Full Text] [Related]
9. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
[TBL] [Abstract][Full Text] [Related]
10. Encephalopathy induced by levetiracetam added to valproate.
Bauer J
Acta Neurol Scand; 2008 May; 117(5):374-6. PubMed ID: 18081909
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
Delanty N; Jones J; Tonner F
Epilepsia; 2012 Jan; 53(1):111-9. PubMed ID: 22050371
[TBL] [Abstract][Full Text] [Related]
12. Levetiracetam extended release for the treatment of patients with partial-onset seizures: A long-term, open-label follow-up study.
Chung S; Ceja H; Gawłowicz J; McShea C; Schiemann J; Lu S
Epilepsy Res; 2016 Feb; 120():7-12. PubMed ID: 26716580
[TBL] [Abstract][Full Text] [Related]
13. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
[TBL] [Abstract][Full Text] [Related]
14. Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers.
Mawhinney E; Craig J; Morrow J; Russell A; Smithson WH; Parsons L; Morrison PJ; Liggan B; Irwin B; Delanty N; Hunt SJ
Neurology; 2013 Jan; 80(4):400-5. PubMed ID: 23303847
[TBL] [Abstract][Full Text] [Related]
15. Anticonvulsant drugs for generalized tonic-clonic epilepsy.
Coppola G; Piccorossi A; Operto FF; Verrotti A
Expert Opin Pharmacother; 2017 Jun; 18(9):925-936. PubMed ID: 28481729
[TBL] [Abstract][Full Text] [Related]
16. Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures.
Maitre NL; Smolinsky C; Slaughter JC; Stark AR
J Perinatol; 2013 Nov; 33(11):841-6. PubMed ID: 24051577
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density in adult patients treated with various antiepileptic drugs.
Beniczky SA; Viken J; Jensen LT; Andersen NB
Seizure; 2012 Jul; 21(6):471-2. PubMed ID: 22541979
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of anti-epileptic drugs-an internet study.
Wieshmann UC; Baker G
Acta Neurol Scand; 2017 May; 135(5):533-539. PubMed ID: 27757951
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam as a possible contributor to acute kidney injury.
Spengler DC; Montouris GD; Hohler AD
Clin Ther; 2014 Aug; 36(8):1303-6. PubMed ID: 24986483
[TBL] [Abstract][Full Text] [Related]
20. Safety of switching from brand-name to generic levetiracetam in patients with epilepsy.
Bosak M; Słowik A; Turaj W
Drug Des Devel Ther; 2017; 11():2287-2291. PubMed ID: 28814836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
